Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2024; 13(01): 017-026
DOI: 10.1055/s-0043-1776288
Original Article
International

Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh

Ashrafun Nessa
1   Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh
,
Thrina Islam
2   Planning, Monitoring & Research Department, National Centre of Cervical and Breast Cancer Screening and Training, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
,
Noor-E-Ferdousi Noor-E-Ferdousi
3   Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
,
Anjuman Sultana 
4   Medical Officer, Mugda Medical College, Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare, Dhaka, Bangladesh
,
Kamrul Hasan Khan
5   Department of Pathology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
,
Harun ur Rashid
6   Planning, Monitoring and Research, Directorate General of Health Services (DGHS), Mohakhali, Dhaka, Bangladesh
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Zoom Image
Anjuman Sultana

Cervical cancer (CC) ranks as the second most common cancer among women in Bangladesh. Unfortunately, due to late-stage diagnosis and inadequate treatment facilities, the mortality rate remains high. The stage at which CC is diagnosed plays a crucial role in predicting a woman's survival. This study aimed to determine the staging patterns of CC at presentation in the colposcopy clinic of Bangabandhu Sheikh Mujib Medical University (BSMMU) and the subsequent management provided to these women. This retrospective study was conducted at the BSMMU colposcopy clinic from January 2019 to June 2020. It included CC cases with known staging, spanning from January 2016 to June 2019. Data were collected from the colposcopy registry book, telephone interviews, and face-to-face discussions during follow-up appointments. The mean age of women diagnosed with CC was 48.59 years (±2 standard deviations). Among the 523 women studied, 107 (20.5%) were diagnosed at stage I, 124 (23.7%) at stage IIA, 240 (45.9%) at stage IIB, while the remaining 52 (9.90%) were diagnosed with Stage III and IV disease. Within the study population, 39 (7.5%) women underwent radical hysterectomy alone, 110 (21.00%) underwent radical hysterectomy followed by adjuvant therapy, and 184 (35.14%) received primary radiotherapy or concurrent chemoradiation. A significant portion of CC cases presented at an early stage, underscoring the importance of an effective screening program to prevent advanced-stage disease and enhance early detection rates. Establishing a patient navigation system immediately after diagnosis is crucial to prevent the loss of follow-up and ensure timely treatment. It is imperative to enhance the healthcare system's capacity to ensure timely treatment for cancer patients.

Keywords

Bangladesh - cervical cancer - colposcopy - management - staging

Authors' Contribution

Ashrafun Nessa helped in development of idea, data analysis and drafting, and editing and finalization of article. Thrina Islam contributed to data collection and analysis. Noor-E-Ferdousi was involved in data curation, literature review, and draft preparation. Anjuman Sultana helped in development of idea. Kamrul Hasan Khan was involved in reviewing and editing of article. Harun ur Rashid contributed to management, coordination, and supervision of research activity and finalization of article. All coauthors have seen and agree with the contents of manuscript.


Ethical Approval

This study obtained ethical approval under the reference number BSMMU/2018/10365, granted on August 28, 2018. Additionally, the research received official approval from the Institutional Review Board of Bangabandhu Sheikh Mujib Medical University in Dhaka, Bangladesh. It is worth noting that this study adheres strictly to the principles and guidelines outlined in the Declaration of Helsinki, ensuring the ethical conduct of research involving human participants.


Data Availability Statement

Data sets used in this study are available from the corresponding authors on reasonable request.




Publication History

Article published online:
21 February 2024

© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
    CrossrefPubMedGoogle Scholar
  • 2 Globocan 2020. Lyon, France: World Health Organization; 2020. International Agency for Research on Cancer
    Google Scholar
  • 3 Sankaranarayanan R, Swaminathan R, Brenner H. et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11 (02) 165-173
    CrossrefPubMedGoogle Scholar
  • 4 Santos C, Muñoz N, Klug S. et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001; 85 (07) 966-971
    CrossrefPubMedGoogle Scholar
  • 5 FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet 2014; 125 (02) 97-98
    CrossrefPubMedGoogle Scholar
  • 6 Villaseñor-Navarro Y, Pacheco-Bravo I, Reyes-Pérez JA. et al. Imaging in cervical cancer. Cerv Cancer; 2017: 133-50
    CrossrefGoogle Scholar
  • 7 Wabinga H, Ramanakumar AV, Banura C, Luwaga A, Nambooze S, Parkin DM. Survival of cervix cancer patients in Kampala, Uganda: 1995-1997. Br J Cancer 2003; 89 (01) 65-69
    CrossrefPubMedGoogle Scholar
  • 8 Kataki AC, Sharma JD, Krishnatreya M. et al. A survival study of uterine cervical patients in the North East India: hospital-cancer registry-based analysis. J Cancer Res Ther 2018; 14 (05) 1089-1093
    CrossrefPubMedGoogle Scholar
  • 9 Ahmed T, Ashrafunnessa Ashrafunnessa, Rahman J. Development of a visual inspection programme for cervical cancer prevention in Bangladesh. Reprod Health Matters 2008; 16 (32) 78-85
    CrossrefPubMedGoogle Scholar
  • 10 Nessa A, Hussain MA, Rahman JN, Rashid MH, Muwonge R, Sankaranarayanan R. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet 2010; 111 (02) 115-118
    CrossrefPubMedGoogle Scholar
  • 11 Basu P, Nessa A, Majid M, Rahman JN, Ahmed T. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines. J Fam Plann Reprod Health Care 2010; 36 (03) 131-134
    CrossrefPubMedGoogle Scholar
  • 12 Nessa A, Rashid MH, E-Ferdous N, Chowdhury A. Screening for and management of high-grade cervical intraepithelial neoplasia in Bangladesh: a cross-sectional study comparing two protocols. J Obstet Gynaecol Res 2013; 39 (02) 564-571
    CrossrefPubMedGoogle Scholar
  • 13 Nessa A, Naud P, Esmy PO. et al. Efficacy, safety, and acceptability of thermal coagulation to treat cervical intraepithelial neoplasia: pooled data from Bangladesh, Brazil and India. Rinsho Fujinka Sanka 2017; 6 (3–4): 58-64
    Google Scholar
  • 14 Holme F, Kapambwe S, Nessa A, Basu P, Murillo R, Jeronimo J. Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low- and lower-middle-income countries. Int J Gynaecol Obstet 2017; 138 (Suppl. 01) 63-68
    CrossrefPubMedGoogle Scholar
  • 15 Bhatla N, Nessa A, Oswal K, Vashist S, Sebastian P, Basu P. Program organization rather than choice of test determines success of cervical cancer screening: case studies from Bangladesh and India. Int J Gynaecol Obstet 2021; 152 (01) 40-47
    CrossrefPubMedGoogle Scholar
  • 16 National Strategy for Cervical Cancer Prevention & Control Bangladesh (2017–2022), DGHS 2018
  • 17 Jain A, Ganesh B, Bobdey SC, Sathwara JA, Saoba S. Sociodemographic and clinical profile of cervical cancer patients visiting in a tertiary care hospital in India. Indian Journal of Medical and Paediatric Oncology 2017; Jul; 38 (03) 291-295
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Ramachandran M, Kannan A, Kiyam W, Prasaad PR, Rao GB. PAP smear findings in premenopausal and post-menopausal women- a comparative study. Res J Med Allied Sci 2016; 1 (01) 14-21
    Google Scholar
  • 19 El-Moselhy EA, Borg HM, Atlam SA. Cervical cancer: sociodemographic and clinical risk factors among adult Egyptian females. Adv Oncol Res Treat. 2016; 1 (106) 1-7
    Google Scholar
  • 20 World Health Organization. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization; Geneva: 2013
    Google Scholar
  • 21 World health organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Second edition.. Geneva: World health organization; 2014
    Google Scholar
  • 22 Muñoz N, Franceschi S, Bosetti C. et al; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359 (9312): 1093-1101
    CrossrefPubMedGoogle Scholar
  • 23 Ferdous J, Begum SA, Ferdous NE, Nahar Q, Khatun SF, Khatun S. Presentation of invasive cervical cancer in Bangladesh. BSMMU J 2013; 6 (01) 29-32
    Google Scholar
  • 24 Afroj S, Banu MA, Sultana S, Jahan R, Rahman S, Begum N. Clinicopathological profile of cervical cancer patients attending in a specialized hospital. J Dhaka Med Coll 2017; 26 (02) 117-121
    CrossrefGoogle Scholar
  • 25 Banu PA, Rukhsana N, Yasmin J, Nahar L. . Original article analysis on the incidence. Staging and Treatment of Carcinoma Cervix at Delta Medical College and Hospital of Bangladesh. Delta Medical College Journal 2013; 1: 4-9
    Google Scholar
  • 26 Kaverappa VB, Prakash B, Kulkarni P, Renuka M. Sociodemographic profile of patients with cervical cancer in a tertiary-care cancer hospital in Mysuru, Karnataka. Int J Med Sci Public Health 2015; 4 (09) 1187-1191
    CrossrefGoogle Scholar
  • 27 Rita R, Singh U, Trivedi V, Chauhan R, Kumari A. Determinants of survival of cervical cancer: a hospital based study. Gynecol Obstet (Sunnyvale) 2017; 7 (437) 2161-0932
    Google Scholar
  • 28 Bindu T, Kumar SS, Ratheesan K, Balasubramanian S. Factors associated with survival and lost to follow-up of cervical cancer patients in a tertiary cancer centre in rural Kerala. Indian J Public Health 2017; 61 (01) 43-46
    CrossrefPubMedGoogle Scholar
  • 29 Mathew A, Sara George P, Kalavathy MC, Padmakumari G, Jagathnath Krishna KM, Sebastian P. Cancer incidence and mortality: District Cancer Registry, Trivandrum, South India. Asian Pac J Cancer Prev 2017; 18 (06) 1485-1491
    PubMedGoogle Scholar
  • 30 Gyenwali D, Khanal G, Paudel R, Amatya A, Pariyar J, Onta SR. Estimates of delays in diagnosis of cervical cancer in Nepal. BMC Womens Health 2014; 14 (01) 29
    CrossrefPubMedGoogle Scholar
  • 31 Haque N, Uddin AFMK, Dey BR, Islam F, Goodman A. Challenges to cervical cancer treatment in Bangladesh: the development of a women's cancer ward at Dhaka Medical College Hospital. Gynecol Oncol Rep 2017; 21 (June): 67-72
    CrossrefPubMedGoogle Scholar
  • 32 Grover S, Xu MJ, Yeager A. et al. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol 2015; 4: 380
    CrossrefPubMedGoogle Scholar
  • 33 Zubizarreta EH, Fidarova E, Healy B, Rosenblatt E. Need for radiotherapy in low and middle income countries – the silent crisis continues. Clin Oncol (R Coll Radiol) 2015; 27 (02) 107-114
    CrossrefPubMedGoogle Scholar